Ads
related to: zinc carnosine for acid refluxebay.com has been visited by 1M+ users in the past month
Search results
Results from the WOW.Com Content Network
Zastaprazan (trade name Jaqbo) is a pharmaceutical drug for gastrointestinal disorders.It is classified as a potassium-competitive acid blocker. [1] [2] In April 2024, it was approved for use in South Korea for the treatment of erosive gastroesophageal reflux disease (GERD). [3]
Zinc L-carnosine (beta-alanyl-L-histidinato zinc [1]) (N-(3-aminopropionyl)-L-histidinato zinc [2]), often simply called zinc carnosine, and also known as polaprezinc, [3] is a mucosal protective [4] [5] chelate compound of zinc and L-carnosine invented by Hamari Chemicals, Ltd. [6] [7] It is a quadridentate 1:1 complex of a polymeric nature. [6]
There are several classes of drugs for acid-related disorders, such as dyspepsia, peptic ulcer disease (PUD), gastroesophageal reflux disease (GORD/GERD), or laryngopharyngeal reflux. The World Health Organization gives drugs in these classes the categorization code ATC code A02.
Vonoprazan, sold under the brand name Voquezna among others, is a first-in-class potassium-competitive acid blocker medication. [2] [1] Vonoprazan is used in form of the fumarate for the treatment of gastroduodenal ulcer (including some drug-induced peptic ulcers) and reflux esophagitis, and can be combined with antibiotics for the eradication of Helicobacter pylori.
Fexuprazan (trade name Fexuclue) is a drug for the treatment of gastroesophageal reflux disease (GERD). [1] It is a potassium-competitive acid blocker. [2] Fexuprazan is approved for use in South Korea and Mexico. [3] [4]
Linaprazan is an experimental drug for the treatment of gastroesophageal reflux disease (GERD). Unlike the proton-pump inhibitors (PPIs) which are typically used to treat GERD, linaprazan is a potassium-competitive acid blocker (P-CAB). [1] [2] Linaprazan was developed by AstraZeneca, but it was not successful in clinical trials. [3]
Ads
related to: zinc carnosine for acid refluxebay.com has been visited by 1M+ users in the past month